CAR T-cell therapy puts lupus into remission in pioneering NHS trial
Five lupus patients in England have achieved remission after receiving CAR T-cell therapy, a genetically modified immune treatment, in an early NHS trial at University College London Hospitals. The therapy works by engineering patients' own T cells to destroy malfunctioning B cells, effectively resetting the immune system, and patients have remained well for over 18 months without lupus medication. If confirmed in larger studies, this could represent a potential cure for lupus and may be applicable to other autoimmune diseases like multiple sclerosis and rheumatoid arthritis.
In a medical breakthrough, five lupus patients treated with CAR T-cell therapy at University College London Hospitals have entered remission, with one patient reporting no symptoms more than 30 years after initial diagnosis. The therapy involves removing T lymphocytes from patients, genetically engineering them to target and destroy malfunctioning B cells, and reinfusing them to reset the immune system. Nine patients with severe lupus who had not responded to previous treatments were enrolled in the trial; five of six receiving a lower dose achieved remission within months, with kidney function stabilizing or improving. One patient, Katie Tinkler, who had been unable to work as a fitness instructor due to severe pain and organ damage, can now ski and dance without lupus medication. Researchers emphasize that while larger studies are needed to confirm long-term efficacy and durability, the results suggest CAR T-cell therapy could transform lupus treatment and potentially cure the disease, with potential applications to other autoimmune conditions.
What's missing
The sources do not specify the cost of the treatment, whether it will be available on the NHS beyond the trial, the timeline for larger confirmatory studies, or detailed safety data beyond the mention of chemotherapy as part of the protocol.
How coverage differed
The Guardian emphasizes the breakthrough and patient testimonial with language like 'revolutionary' and 'cure,' while the BBC provides more cautious framing by noting uncertainties about treatment duration and including the caveat that one patient experienced a flare-up after 11 months. The BBC also provides more technical detail about the mechanism and explicitly states 'it is still uncertain how long the treatment will last.'
What different sources said
- The GuardianLeft
Lupus patients in England in remission after pioneering NHS trial of GM therapy
- BBC Top StoriesCenter
'I've never been this good' – revolutionary immune reset puts lupus in remission
Lupus patients in England in remission after pioneering NHS trial of GM therapy
Related
NT Government Terminates $1.1 Million Private Midwife Contract
The Northern Territory government has terminated a $1.1 million contract with Darwin midwife Claire Marks to establish a private midwifery service. The contract was awarded in September despite Marks being under investigation by the Nursing and Midwifery Board of Australia, which later imposed conditions restricting her practice to supervised work only. The termination follows concerns raised by doctors about governance and safety, though no clinical services had commenced under the contract.
UK to Offer Meningitis B Vaccine to Million Young People Following Outbreak
The UK government has announced a one-off vaccination programme offering two doses of the meningitis B vaccine to approximately one million teenagers in their final school year and young people under 25 starting university, beginning in late July 2026. The decision follows an unprecedented outbreak in Kent and clusters in Dorset and Berkshire that resulted in three deaths, with all cases covered by the Bexero vaccine. The programme aims to protect those at highest risk during university entry, when increased social mixing and shared accommodation elevate transmission risk.
NHS Investigation Finds Gender Care Failures at Brighton GP Clinic, 78 Children Prescribed Medication Inappropriately
An NHS safety investigation found that a Brighton GP practice (WellBN) inappropriately prescribed gender-related medications to 78 children under 18 between February 2023 and December 2025, including some under age 13, often without proper face-to-face appointments or necessary medical oversight. The clinic lacked qualified clinicians and specialist support, failed to conduct required blood tests, and provided treatment that fell "far short of what could be considered safe or appropriate." NHS England has suspended prescriptions to children at the clinic and referred clinicians to medical regulators, highlighting systemic failures in a service created to address long waiting times for specialist gender care.